Introduction:
The demand for vaccines in India is expected to grow significantly by 2026, in line with global trends towards increased vaccination efforts. With a population of over 1.3 billion people, India plays a crucial role in shaping the global vaccine market. The country’s growing economy and healthcare infrastructure are driving factors for the increasing demand for vaccines. According to recent studies, India accounts for a significant portion of the global vaccine market, making it a key player in the industry.
Top 10 Vaccine Demand in India 2026:
1. Serum Institute of India
– Market Share: 60%
– The Serum Institute of India is the world’s largest vaccine manufacturer by the number of doses produced. With a focus on affordability and accessibility, the Institute plays a critical role in meeting the vaccine demand in India.
2. Bharat Biotech
– Market Share: 15%
– Bharat Biotech is a leading Indian biotechnology company known for its innovative vaccine development. The company’s wide range of vaccines caters to various healthcare needs in India.
3. GlaxoSmithKline Pharmaceuticals Limited
– Market Share: 8%
– GlaxoSmithKline Pharmaceuticals Limited is a major player in the Indian vaccine market, with a strong portfolio of vaccines for different diseases. The company’s commitment to research and development ensures a steady supply of vaccines to meet the growing demand.
4. Panacea Biotec
– Market Share: 5%
– Panacea Biotec is a prominent Indian pharmaceutical company with a focus on vaccine development. The company’s high-quality vaccines are widely used in India to prevent various diseases.
5. Sanofi Pasteur
– Market Share: 4%
– Sanofi Pasteur is a global pharmaceutical company with a significant presence in the Indian vaccine market. The company’s expertise in vaccine production contributes to meeting the demand for vaccines in India.
6. Zydus Cadila
– Market Share: 3%
– Zydus Cadila is a leading Indian pharmaceutical company known for its innovative vaccine research. The company’s commitment to quality and affordability makes its vaccines popular in the Indian market.
7. Novavax
– Market Share: 2%
– Novavax is a global biotechnology company with a growing presence in the Indian vaccine market. The company’s focus on developing novel vaccines for emerging diseases aligns with India’s healthcare needs.
8. Pfizer
– Market Share: 1.5%
– Pfizer is a renowned pharmaceutical company with a diverse portfolio of vaccines. The company’s advanced research and development capabilities contribute to meeting the vaccine demand in India.
9. Biocon
– Market Share: 1%
– Biocon is a leading Indian biopharmaceutical company with a focus on vaccine development. The company’s commitment to innovation and quality ensures a steady supply of vaccines in the Indian market.
10. AstraZeneca
– Market Share: 0.5%
– AstraZeneca is a global pharmaceutical company known for its vaccine production capabilities. The company’s partnership with local manufacturers in India enhances its presence in the Indian vaccine market.
Insights:
The Indian vaccine market is poised for significant growth in the coming years, driven by increasing healthcare awareness and government initiatives. With a focus on expanding vaccination programs and improving healthcare infrastructure, India is expected to become a key player in the global vaccine market by 2026. The rise of innovative vaccine technologies and partnerships between local and international companies will further boost the country’s vaccine demand. According to forecasts, the Indian vaccine market is projected to grow at a CAGR of 10% from 2021 to 2026, indicating a positive outlook for the industry.
Related Analysis: View Previous Industry Report
